Treating Peri and Postnatal Depression & Anxiety by Stevenson, Emily M.
University of North Dakota
UND Scholarly Commons
Physician Assistant Scholarly Project Posters Department of Physician Studies
2018
Treating Peri and Postnatal Depression & Anxiety
Emily M. Stevenson
University of North Dakota
Follow this and additional works at: https://commons.und.edu/pas-grad-posters
Part of the Psychiatric and Mental Health Commons
This Poster is brought to you for free and open access by the Department of Physician Studies at UND Scholarly Commons. It has been accepted for
inclusion in Physician Assistant Scholarly Project Posters by an authorized administrator of UND Scholarly Commons. For more information, please
contact zeineb.yousif@library.und.edu.
Recommended Citation
Stevenson, Emily M., "Treating Peri and Postnatal Depression & Anxiety" (2018). Physician Assistant Scholarly Project Posters. 24.
https://commons.und.edu/pas-grad-posters/24
Treating Peri & Postnatal Depression & Anxiety 
Emily Stevenson, PA-S
Department of Physician Assistant Studies, University of North Dakota School of Medicine & Health Sciences
Grand Forks, ND  58202-9037
Abstract
Introduction
 First line treatment for severe or chronic major depression disorder in 
adults: a referral to behavioral health in combination with 
antidepressant therapy (National Guideline Clearinghouse, 2012). 
Medication classes include: selective serotonin reuptake inhibitor 
(SSRI), tricyclic antidepressants (TCA), serotonin-norepinephrine 
reuptake inhibitor (SNRI), norepinephrine reuptake inhibitor (NRI), 
and dopamine agonists (DA).
 Prevalence of Prenatal Depression: 6-13% (Charlton et al.,  2014).








The literature review collectively found that both antidepressant 
treatment and non-pharmacotherapy such as CBT are beneficial in 
women suffering from depression and anxiety in the perinatal or 
postpartum time. However, pharmacotherapy methods tend to 
have a positive effect in a shorter amount of time when compared 
to psychosocial therapies. Unfortunately, these antidepressant 
medications have been shown to have a potentially negative 
impact on the fetus during pregnancy. For the breastfeeding 
infant, fluoxetine has been shown to be present in the serum of 
exposed infants.
The objective of this research is to evaluate the commonly prescribed 
treatment methods for prenatal and postnatal depression, focusing on the 
efficacy of antidepressant medications and nonpharmacologic 
treatments while evaluating the effects these medications have on the 
fetus/breastfeeding infant. 
The method of research included 15 studies completed with within the 
past ten years on women who were pregnant or who had delivered a 
baby within the past 12 months. One study did evaluate long-term 
effects on offspring, which included a participant number of 3,342 
children who were exposed to antidepressants during pregnancy. The 
total number of participants in the studies were 8,069 women.
 Limitations within the data are due to small sample sizes in several of 
the studies and few available studies that directly evaluate this 
population of women and children. 
Data results suggest that while cognitive group therapy does provide 
depression symptom improvement in prenatal and postnatal depression 
and anxiety, antidepressant medications tend to have a positive effect 
earlier in treatment. Unfortunately, many of these antidepressant 
medications have also been proven to have both short and long tern 
effects on the offspring exposed to pharmacologic treatment.
In the pregnant and breastfeeding population, what 
is the efficacy of antidepressant medication treatment 
for patients diagnosed with depression and/or 
anxiety?
In pregnant patients diagnoses with depression 
and/or anxiety, what are the fetal effects resulting 
from use of antidepressants during pregnancy?
In breastfeeding patients diagnosed with depression 
and/or anxiety, are there effects caused from the 
transfer of antidepressant medications from mother 
to infant during lactation?
In patients diagnosed with depression and/or anxiety 
during pregnancy and postpartum, what is the 
effectiveness of treatment options such as cognitive 
behavioral health therapy?
 Depression symptoms are thought to be caused by a deficiency of 
synaptic neurotransmitters such as serotonin, norepinephrine, and 
dopamine (Bardal et al., 2011).
 Goals of antidepressant medication: improve the patient’s mood by 
altering the neurotransmitter receptors and transporters to increase 
the availability of the neurotransmitters within the synaptic cleft. 
 Antidepressant Medication Efficacy
 Sharp et al. (2010) found that 45% of women receiving SSRI 
treatment  responded in 4 weeks compared to therapy sessions 
in which only 20% improved after 4 weeks. At 18 weeks of 
treatment, both medication and therapy responses were similar.
 Antidepressant Medication Effects on the Fetus
 Klieger-Grossman et al. (2012) found that infants exposed to 
escitalopram (SSRI) had an increased risk of low birth weight 
(9.9%) compared to other antidepressants (3.6%). Spontaneous 
abortions were almost two times as common in antidepressant 
medications (16%) when compared to controls (8.5%).
 Rai et al. (2017) found that 4.1% of children exposed to 
antidepressants were diagnosed with autism, compared to 
2.9% of children not exposed to medications.
 Antidepressant Medication Effects on the Breastfeeding Infant
Weissman et al. (2004) found that fluoxetine had the highest 
serum levels in breastfeeding infants (22%) compared to 
paroxetine, nortriptyline, and sertraline.
 Non-pharmacotherapy treatment effectiveness
 Van Lieshout et al. (2017) found that group cognitive 
behavioral therapy (CBT) showed statistical improvement of 
depressive symptoms in 80% of women receiving treatment 
over 9 weeks.
 A Cochrane Review found shat interpersonal psychotherapy 
had increased improvement rates when compared to parenting 
education programs (Dennis et al., 2007). 
 The standard practice guidelines for treatment and management 
of adult depression and anxiety include both cognitive behavioral 
therapy (CBT) and antidepressant medications.
The research gathered in this literature review do suggest that 
antidepressant medications tend to have a quicker response rate for 
improvement of symptoms when compared to psychosocial 
therapies. CBT does show symptom improvement as well, but 
tends to take more sessions to reach the same improvement rate as 
medication therapy.
Unfortunately, there continues to be research showing that the 
commonly-used antidepressant medications have effects on 
offspring. During pregnancy, spontaneous abortions are more 
common across all antidepressant medication classes. Smaller 
birth weight and earlier delivery rates are associated with women 
who have taken antidepressant medications.
Although not studied thoroughly, antidepressant metabolites have 
been shown to appear in the serum of lactating infants exposed to 
antidepressants. 
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Statement of the Problem
One difficult area in the treatment of both depression and anxiety is in 
the prenatal and breastfeeding patient population. Providers and patients 
must work together to determine the best path of action for this unique 
situation of caring for both the pregnant patient's mental health and her 
unborn child.  
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Baseline Depression and Global Functioning of
Women With or Without Exposure to SSRI 
Antidepressants
and Depression During Pregnancy
a Within each box, the white line represents the 
median value. The
top and bottom edges of the box represent the 75th 
and 25th percentiles,
respectively; these define the interquartile range. 
Each bar
attached to the box represents 1.5 times the 
interquartile range;
the filled circles are outliers.
b 29-item Structured Interview Guide for the 
Hamilton Depression
Rating Scale With Atypical Depression Supplement 
(29).
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